Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Non Operating Income: 2010-2012

Historic Non Operating Income for Iovance Biotherapeutics (IOVA) over the last 2 years, with Sep 2012 value amounting to $953,739.

  • Iovance Biotherapeutics' Non Operating Income rose 22090.75% to $953,739 in Q3 2012 from the same period last year, while for Sep 2012 it was -$762,222, marking a year-over-year decrease of 8.43%. This contributed to the annual value of $200,000 for FY2015, which is 3233.33% up from last year.
  • Per Iovance Biotherapeutics' latest filing, its Non Operating Income stood at $953,739 for Q3 2012, which was down 27.70% from $1.3 million recorded in Q2 2012.
  • Iovance Biotherapeutics' Non Operating Income's 5-year high stood at $1.3 million during Q2 2012, with a 5-year trough of -$2.6 million in Q1 2012.
  • For the 3-year period, Iovance Biotherapeutics' Non Operating Income averaged around -$183,148, with its median value being -$125,091 (2010).
  • Over the last 5 years, Iovance Biotherapeutics' Non Operating Income had its largest YoY gain of 22,090.75% in 2012, and its largest YoY loss of 2,906.21% in 2012.
  • Over the past 3 years, Iovance Biotherapeutics' Non Operating Income (Quarterly) stood at -$245,845 in 2010, then slumped by 62.12% to -$398,556 in 2011, then surged by 22,090.75% to $953,739 in 2012.
  • Its Non Operating Income stands at $953,739 for Q3 2012, versus $1.3 million for Q2 2012 and -$2.6 million for Q1 2012.